Seeking Alpha

Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off...

Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off until next March after the start of its 2014 fiscal year. The company notes that U.S. regulators are asking for more information about its SOLX whole-blood collection system as part of a resubmitted marketing application.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs